Vinge has advised Moank in connection with the issuance of Additional Tier 1 Capital of SEK 150 million

Vinge advises ABGSC in connection with EQL Pharma’s inaugural bond issuance

Vinge has advised ABG Sundal Collier in connection with EQL Pharma AB (publ)’s ( “EQL”) inaugural issuance of SEK 350,000,000 senior secured bonds within a framework of up to SEK 700,000.

Vinge represents Sedana Medical AB in the acquisition of Innovatif Cekal

Vinge has represented Sedana Medical AB (publ) in connection with the acquisition of Innovatif Cekal. Innovatif Cekal, based in Klang near Kuala Lumpur, Malaysia, is a manufacturer of medical devices. This acquisition enhances Sedana Medical's control over its supply chain and improves profitability through reduced cost of goods.

Vinge advises Infranity in connection with the acquisition of Nordic Re-Finance AB

Vinge has advised Infranity, a private equity firm specializing in infrastructure investments, in connection with its acquisition of a majority stake in Nordic Re-Finance AB, a Scandinavian locomotives lessor. The acquisition brings ambitious development plans for Nordic Re-Finance AB, including expansion into new geographical areas.